← Leaderboards
Jay Wyatt Warrick
Salus Discovery, Llc
$3,077,992
Attributed
$5,005,547
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,005,547 · 4
By mechanism
R44$4,729,811 · 3
R43$275,736 · 1
Top collaborators
- Brianna Mullins4 shared
- Cody Carrell2 shared
- Scott M Berry1 shared
Most similar at Salus Discovery, Llc
Same institution · by research overlap
- Brianna Mullins$1,866,165
- Cody Carrell$745,861
Others in their field
Other Emerging Leaders on “Cost”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Scott Topper · Broad Institute, Inc.$77,958,806
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Mark Marino · Venturewell$48,913,644
- John Damon Chodera · Sloan-Kettering Inst Can Research$48,367,817
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
Research focus
CostBenchmarkingPreparationPoint Of CareSamplingTechnologyDetectionDevicesTuberculosisPerformanceCessation Of LifeFundingTuberculosis DiagnosticsUrineCommercializationResearch Clinical TestingEvaluationClinical SensitivityLaboratoriesLateral Flow AssayDiagnosticDesignPilot ProjectsCause Of Death
Grant awards (8)
3STEP: A swab-seal-read assay for tuberculosis and RIF resistance enabled by autonomous extraction technology$1,000,000
R44 · FY2025 · AI · contact PI
Flow Direct: Next Generation Urine LFA for TB Diagnosis in Point-of-Care Settings$916,195
R44 · FY2025 · AI · contact PI
Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology$818,507
R44 · FY2024 · HD
Flow Direct: Next Generation Urine LFA for TB Diagnosis in Point-of-Care Settings$300,000
R44 · FY2024 · AI · contact PI
3STEP: A swab-seal-read assay for tuberculosis and RIF resistance enabled by autonomous extraction technology$295,893
R44 · FY2024 · AI · contact PI
3STEP: A swab-seal-read, point-of-care nucleic acid test to address disparity in STI screening and prevention$275,736
R43 · FY2024 · AI
Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology$962,850
R44 · FY2022 · HD
Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology$436,366
R44 · FY2020 · HD